Edition:
India

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

4.40USD
9:43pm IST
Change (% chg)

$0.05 (+1.15%)
Prev Close
$4.35
Open
$4.35
Day's High
$4.42
Day's Low
$4.32
Volume
17,174
Avg. Vol
62,274
52-wk High
$8.68
52-wk Low
$3.62

Latest Key Developments (Source: Significant Developments)

Calcitriol New Contract Manufacturing Submission Receives FDA Approval
Monday, 16 Jul 2018 

July 16 (Reuters) - Rockwell Medical Inc ::CALCITRIOL NEW CONTRACT MANUFACTURING SUBMISSION RECEIVES FDA APPROVAL AND ALLOWS ROCKWELL MEDICAL COMMERCIALIZATION OF CALCITRIOL.ROCKWELL MEDICAL INC - CO DOES NOT EXPECT CALCITRIOL SALES TO HAVE A MATERIAL IMPACT ON ITS TOTAL REVENUE FOR 2018.  Full Article

Rockwell Medical Says Plante & Moran Resigning As Independent Registered Public Accounting Firm
Wednesday, 27 Jun 2018 

June 27 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL - PLANTE & MORAN PLLC NOTIFIED CHAIR OF AUDIT COMMITTEE OF BOARD IT WAS RESIGNING AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.ROCKWELL MEDICAL - IN LETTER DATED JUNE 22, PLANTE IDENTIFIED SOME REPORTABLE EVENTS RELATING TO FINANCIAL STATEMENTS IN FORM 10-Q FOR PERIOD ENDED MARCH 31, 2018.  Full Article

Rockwell Medical Says Court Ordered Co Not To Make Any Material Changes Unless First Reviewed By Court
Wednesday, 20 Jun 2018 

June 19 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL INC - COURT ISSUED ORDER IN MATTER ROCKWELL MEDICAL, INC. V. ROBERT CHIOINI AND THOMAS KLEMA.ROCKWELL MEDICAL - COURT ORDERED BOARD & MANAGEMENT OF CO NOT MAKE ANY MATERIAL CHANGES TO CO UNLESS FIRST REVIEWED BY COURT.ROCKWELL MEDICAL INC - COURT ORDERED CO'S 2018 ANNUAL SHAREHOLDER MEETING CURRENTLY SCHEDULED TO BE HELD ON JUNE 21, BE ADJOURNED FOR 30 DAYS.ROCKWELL MEDICAL INC - PARTIES ARE SCHEDULED TO ENGAGE IN COURT-ORDERED MEDIATION ON, JUNE 19, 2018.  Full Article

Rockwell Medical Provides Update On Commercial Strategy
Thursday, 7 Jun 2018 

June 7 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL PROVIDES UPDATE ON COMMERCIAL STRATEGY.ROCKWELL MEDICAL INC - COMPANY TO MOVE FORWARD WITH COMMERCIALIZATION OF TRIFERIC.ROCKWELL MEDICAL - CONCLUDED IT SHOULD MOVE FORWARD WITHOUT ASSUMING IT WILL GET TRANSITIONAL DRUG ADD-ON PAYMENT ADJUSTMENT FOR TRIFERIC IN NEAR TERM.ROCKWELL MEDICAL - CONCLUDED IT IS IN BEST INTERESTS OF CO'S SHAREHOLDERS TO IMMEDIATELY MOVE AHEAD WITH COMMERCIAL PLANNING, LAUNCH OF TRIFERIC.  Full Article

Rockwell Medical Voted To Terminate Thomas Klema As VP, CFO, Secretary And Treasurer, Effective Immediately
Saturday, 26 May 2018 

May 25 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL - ON MAY 24, VOTED TO TERMINATE EMPLOYMENT OF THOMAS KLEMA AS VP, CFO, SECRETARY AND TREASURER, EFFECTIVE IMMEDIATELY.ON MAY 25, BOARD APPOINTED DAVID KULL AS COMPANY'S PRINCIPAL ACCOUNTING OFFICER - SEC FILING.ROCKWELL-ON MAY 25 CIRCUIT COURT FOR OAKLAND COUNTY ISSUED STIPULATED ORDER RESULTING IN TEMPORARY ESTRAINING ORDER AGAINST ROBERT CHIOINI, THOMAS KLEMA.ROCKWELL MEDICAL - CIRCUIT COURT ISSUED STIPULATED ORDER DUE TO CO FILING REQUEST FOR DECLARATORY RELIEF, TEMPORARY RESTRAINING ORDER AGAINST CHIOINI, KLEMA.COURT ALSO ORDERED PARTIES TO ENGAGE IN MEDIATION DURING THIS 21-DAY PERIOD IN AN EFFORT TO RESOLVE UNDERLYING MATTER.ROCKWELL MEDICAL - COURT ALSO REQUESTED BOARD TO REFRAIN FROM MAKING ANY MATERIAL DECISIONS REGARDING MATTER WITHOUT FIRST ADDRESSING TO COURT.COURT ENTERED AN ORDER THAT FOR 21 DAYS CHIOINI AND KLEMA CANNOT ENTER COMPANY'S FACILITIES, CONTACT COMPANY'S EMPLOYEES.ROCKWELL MEDICAL - COURT ORDER ALSO DETAILED OTHER RESTRAINS, SUCH AS CHIOINI & KLEMA CANNOT HOLD OUT TO PUBLIC AS CO'S OFFICERS, & OTHERS.  Full Article

Rockwell Medical Says Independent Directors Determined CEO Termination Not Effective
Wednesday, 23 May 2018 

May 23 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL SAYS DETERMINATION OF NON-CONFLICTED INDEPENDENT DIRECTORS WAS THAT CEO TERMINATION WAS NOT EFFECTIVE - SEC FILING.ROCKWELL MEDICAL - CEO CONTINUES TO SERVE AS CEO CONSISTENT WITH TERMS OF HIS EMPLOYMENT AGREEMENT.ROCKWELL MEDICAL - CEO THROUGH COUNSEL NOTIFIED SEC OF ACTION TAKEN BY DIRECTORS WHOSE CONDUCT IS DISCUSSED IN DEMAND LETTER.ROCKWELL MEDICAL INC - INTERNAL INVESTIGATION IS PROCEEDING UNDER TWO NON-CONFLICTED INDEPENDENT DIRECTORS PATRICK BAGLEY AND RONALD BOYD..ROCKWELL MEDICAL - INDEPENDENT DIRECTORS HIRED INDEPENDENT COUNSEL TO CONDUCT INTERNAL INVESTIGATION IN RESPONSE TO SHAREHOLDER DEMAND LETTER.  Full Article

Rockwell Medical Announces CEO Transition
Wednesday, 23 May 2018 

May 22 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL ANNOUNCES CEO TRANSITION.BOARD OF DIRECTORS HAS FORMED A SPECIAL TRANSITION COMMITTEE.BOARD ANNOUNCED THAT CO'S PRESIDENT AND CEO, ROBERT CHIOINI, HAS BEEN TERMINATED FROM HIS POSITIONS, EFFECTIVE IMMEDIATELY.ROCKWELL MEDICAL - CHIOINI HAS RESIGNED AS A MEMBER OF THE BOARD AND WILL NOT STAND FOR REELECTION AT THE 2018 ANNUAL MEETING OF SHAREHOLDERS.BOARD HAS INITIATED A FORMAL SEARCH PROCESS AND RETAINED A LEADING EXECUTIVE SEARCH FIRM TO IDENTIFY A PERMANENT CEO.SPECIAL TRANSITION COMMITTEE WILL REMAIN IN PLACE UNTIL A NEW CEO IS APPOINTED.SPECIAL TRANSITION COMMITTEE TO COMPRISE INDEPENDENT DIRECTORS BEN WOLIN, LISA COLLERAN AND JOHN COOPER.  Full Article

Double Medical Technology announces 2017 dividend payment
Tuesday, 24 Apr 2018 

April 24(Reuters) - Double Medical Technology Inc <002901.SZ>:Says plans to pay cash dividend of 4.00 yuan per 10 shares (before tax) to the company's shareholders for 2017.  Full Article

Rockwell Medical Signs License Agreement With Quimica Europea To Commercialize Triferic In Peru
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL SIGNS EXCLUSIVE LICENSE AGREEMENT WITH QUIMICA EUROPEA TO COMMERCIALIZE TRIFERIC IN PERU.ROCKWELL MEDICAL - SIGNED LICENSE & MANUFACTURING SUPPLY DEAL WITH QUIMICA EUROPEA FOR RIGHTS TO COMMERCIALIZE TRIFERIC FOR ESRD PATIENTS IN PERU.ROCKWELL MEDICAL INC- QUIMICA EUROPEA WILL BECOME EXCLUSIVE DISTRIBUTOR FOR TRIFERIC IN PERU FOR AN INITIAL COMMERCIAL TERM OF FIVE YEARS.ROCKWELL MEDICAL INC - ROCKWELL RETAINS MANUFACTURING RESPONSIBILITY OF ALL PRODUCTS.ROCKWELL MEDICAL- QUIMICA TO ASSUME ALL REGULATORY RESPONSIBILITIES,RELATED EXPENSES IN OBTAINING GOVERNMENT COMMERCIAL MARKETING APPROVAL FOR TRIFERIC.  Full Article

Richmond Brothers Says On Nov 22, Entered Into Settlement And Standstill Agreement With Rockwell Medical
Tuesday, 28 Nov 2017 

Nov 27 (Reuters) - Rockwell Medical Inc ::RICHMOND BROTHERS INC​ SAYS ON NOVEMBER 22, ENTERED INTO SETTLEMENT AND STANDSTILL AGREEMENT WITH ROCKWELL MEDICAL INC - SEC FILING.RICHMOND BROTHERS-PURSUANT TO SETTLEMENT,STANDSTILL AGREEMENT, ROCKWELL MEDICAL AGREED TO APPOINT, ONE ADDITIONAL MEMBER TO BOARD NO LATER THAN FEB 15, 2018.RICHMOND BROTHERS - STANDSTILL PERIOD SHALL TERMINATE ON FEB 15, 2018 IN EVENT THAT ADDITIONAL DIRECTOR NOT APPOINTED TO BOARD PRIOR TO FEB 15, 2018.RICHMOND BROTHERS - DURING STANDSTILL PERIOD, RICHMOND PARTIES AGREED NOT TO ACQUIRE OVER MORE THAN 12% OF ROCKWELL MEDICAL'S OUTSTANDING SHARES.  Full Article